Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.215 USD | -9.28% | -27.85% | -77.72% |
Jun. 04 | Apollomics Announces Vebreltinib Data At the 2024 American Society of Clinical Oncology Annual Meeting | CI |
May. 08 | Apollomics, Inc. Appoints Robert Lin to the Board of Directors | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 23.59M |
---|---|---|---|---|---|
Net income 2024 * | -65M | Net income 2025 * | - | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.33
x | P/E ratio 2025 * |
-
| Employees | 45 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 47.96% |
1 day | -9.28% | ||
1 week | -27.85% | ||
Current month | -27.85% | ||
1 month | -45.79% | ||
3 months | -71.14% | ||
6 months | -74.25% | ||
Current year | -77.72% |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 0.215 | -9.28% | 750,296 |
24-06-06 | 0.237 | -1.66% | 381,616 |
24-06-05 | 0.241 | -6.95% | 761,766 |
24-06-04 | 0.259 | -8.16% | 650,224 |
24-06-03 | 0.282 | -5.37% | 431,153 |
Delayed Quote Nasdaq, June 07, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-77.72% | 23.59M | |
+18.72% | 125B | |
+14.19% | 108B | |
-4.93% | 24.21B | |
+0.73% | 22.78B | |
-10.79% | 17.96B | |
-41.74% | 16.43B | |
-13.31% | 16.37B | |
+2.44% | 13.58B | |
+27.89% | 11.66B |
- Stock Market
- Equities
- APLM Stock